Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

ARTIFICIAL PANCREAS: THE FUTURE OF DIABETES TECHNOLOGY

Healthcare Radius

|

April 2025

With evolving technology in the medical sector, several advancements are expected to make artificial pancreas systems even more effective.

- Dr. Samith A Shetty

ARTIFICIAL PANCREAS: THE FUTURE OF DIABETES TECHNOLOGY

Diabetes is a chronic health condition that requires constant monitoring and adjustment. It is characterized by the failure of insulin to control blood sugar levels. It has two main types, i.e., type 1 and type 2. People with diabetes must carefully track blood sugar levels, calculate insulin doses, and accordingly make lifestyle choices. Even with the best efforts, there can be unexpected fluctuations, making diabetes management a challenging process.

With advancements in the medical sector, the artificial pancreas has emerged as a promising technology that automates insulin delivery based on real-time glucose levels. This offers a way to maintain more stable blood sugar control without needing manual adjustments. It is a significant leap in diabetes management, giving patients more freedom and minimizing the risks associated with blood sugar fluctuations.

imageHOW ARTIFICIAL PANCREAS WORK

The artificial pancreas is a closed-loop system which tracks glucose levels continuously and delivers the appropriate amount of insulin. It consists of three main components. A Continuous Glucose Monitor, or CGM, is a small sensor placed under the skin that measures glucose levels throughout the day and night. The real-time data is sent to a control system which allows immediate adjustments.

Then an Insulin Infusion Pump delivers insulin through a small tube (Catheter) which has a needle inserted under the skin. It stays in the same place for several days. This replaces the need for multiple daily injections and ensures the availability of insulin when needed.

Healthcare Radius'den DAHA FAZLA HİKAYE

Healthcare Radius

Healthcare Radius

ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL

Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?

If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.

time to read

3 mins

September 2025

Healthcare Radius

Healthcare Radius

HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY

HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT

Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA

Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI

Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM

SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL

Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.

time to read

1 min

September 2025

Healthcare Radius

Healthcare Radius

INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS

Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.

time to read

9 mins

September 2025

Listen

Translate

Share

-
+

Change font size